A fungal infection by any of the Candida species in a sterile body compartment.
Comprehensive, easy-to-understand information about this condition
How we create this content →The limited documentation surrounding invasive candidiasis is primarily due to its rarity and the challenges in systematically studying such a complex condition. As it affects a relatively small population, comprehensive clinical studies have been scarce. Additionally, the variability in clinical presentation makes it difficult to establish a standardized profile, further complicating the documentation process.
To navigate your care for invasive candidiasis, consider consulting with an infectious disease specialist who has experience in fungal infections. They can provide targeted management strategies and access to potential clinical trials. Additionally, the National Organization for Rare Disorders (NORD) offers resources for patients with rare diseases, which can be found at rarediseases.org. Participating in clinical trials may also provide access to new therapies and contribute to the understanding of this condition.
Currently, there is ongoing research into invasive candidiasis, with fosmanogepix being an orphan drug designated for this condition. There are also 13 active clinical trials exploring various aspects of invasive candidiasis treatment and management. For more information on these trials, you can visit ClinicalTrials.gov and search for invasive candidiasis: https://clinicaltrials.gov/search?cond=candidiasis%2C%20invasive.
Actionable guidance for navigating care for candidiasis, invasive
To navigate your care for invasive candidiasis, consider consulting with an infectious disease specialist who has experience in fungal infections. They can provide targeted management strategies and access to potential clinical trials. Additionally, the National Organization for Rare Disorders (NORD) offers resources for patients with rare diseases, which can be found at rarediseases.org. Participating in clinical trials may also provide access to new therapies and contribute to the understanding of this condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding invasive candidiasis is primarily due to its rarity and the challenges in systematically studying such a complex condition. As it affects a relatively small population, comprehensive clinical studies have been scarce. Additionally, the variability in clinical presentation makes it difficult to establish a standardized profile, further complicating the documentation process.
To navigate your care for invasive candidiasis, consider consulting with an infectious disease specialist who has experience in fungal infections. They can provide targeted management strategies and access to potential clinical trials. Additionally, the National Organization for Rare Disorders (NORD) offers resources for patients with rare diseases, which can be found at rarediseases.org. Participating in clinical trials may also provide access to new therapies and contribute to the understanding of this condition.
Currently, there is ongoing research into invasive candidiasis, with fosmanogepix being an orphan drug designated for this condition. There are also 13 active clinical trials exploring various aspects of invasive candidiasis treatment and management. For more information on these trials, you can visit ClinicalTrials.gov and search for invasive candidiasis: https://clinicaltrials.gov/search?cond=candidiasis%2C%20invasive.
Actionable guidance for navigating care for candidiasis, invasive
To navigate your care for invasive candidiasis, consider consulting with an infectious disease specialist who has experience in fungal infections. They can provide targeted management strategies and access to potential clinical trials. Additionally, the National Organization for Rare Disorders (NORD) offers resources for patients with rare diseases, which can be found at rarediseases.org. Participating in clinical trials may also provide access to new therapies and contribute to the understanding of this condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding invasive candidiasis is primarily due to its rarity and the challenges in systematically studying such a complex condition. As it affects a relatively small population, comprehensive clinical studies have been scarce. Additionally, the variability in clinical presentation makes it difficult to establish a standardized profile, further complicating the documentation process.
To navigate your care for invasive candidiasis, consider consulting with an infectious disease specialist who has experience in fungal infections. They can provide targeted management strategies and access to potential clinical trials. Additionally, the National Organization for Rare Disorders (NORD) offers resources for patients with rare diseases, which can be found at rarediseases.org. Participating in clinical trials may also provide access to new therapies and contribute to the understanding of this condition.
Currently, there is ongoing research into invasive candidiasis, with fosmanogepix being an orphan drug designated for this condition. There are also 13 active clinical trials exploring various aspects of invasive candidiasis treatment and management. For more information on these trials, you can visit ClinicalTrials.gov and search for invasive candidiasis: https://clinicaltrials.gov/search?cond=candidiasis%2C%20invasive.
Actionable guidance for navigating care for candidiasis, invasive
To navigate your care for invasive candidiasis, consider consulting with an infectious disease specialist who has experience in fungal infections. They can provide targeted management strategies and access to potential clinical trials. Additionally, the National Organization for Rare Disorders (NORD) offers resources for patients with rare diseases, which can be found at rarediseases.org. Participating in clinical trials may also provide access to new therapies and contribute to the understanding of this condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 31, 2026
Consider asking your healthcare providers these condition-specific questions
European rare disease database
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease